A Novel Complex Regulates cardiac actin Gene Expression through Interaction of Emb, a Class VI POU Domain Protein, MEF2D, and the Histone Transacetylase p300

Molecular and Cellular Biology

Volumn 24, Issue 7, 2004, Pages 2944-2957

  Molinari, S ^b   Relaix, F ^a   Lemonnier, M ^a   Kirschbaum, B ^c   Schafer B ^d   Buckingham, M ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CLASS VI POU DOMAIN PROTEIN; DEOXYRIBONUCLEASE I; HISTONE TRANSACETYLASE P300; MYOD PROTEIN; PROTEIN EMB; PROTEIN MEF2D; PROTEIN OCT1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AT RICH SEQUENCE; CHROMATIN; COMPLEX FORMATION; CONTROLLED STUDY; ENHANCER REGION; GENE ACTIVATION; GENE EXPRESSION; HEART; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; SKELETAL MUSCLE; TRANSGENE; TRANSGENIC MOUSE;

ACETYLTRANSFERASES; ACTINS; ANIMALS; BASE SEQUENCE; CELL CYCLE PROTEINS; CELL LINE; DNA FOOTPRINTING; DNA-BINDING PROTEINS; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION; HISTONE ACETYLTRANSFERASES; HISTONES; MACROMOLECULAR SUBSTANCES; MICE; MICE, INBRED C3H; MOLECULAR SEQUENCE DATA; MYOCARDIUM; MYOGENIC REGULATORY FACTORS; SEQUENCE ALIGNMENT; TRANSCRIPTION FACTORS;

ANIMALIA; MUS MUSCULUS;

EID: 1642335533     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.7.2944-2957.2004     Document Type: Article

References (69)

1. Andersen, B., M. D. Schonemann, R. V. Pearse, K. Jenne, J. Sugarman, and M. G. Rosenfeld. 1993. Bnr 5 is a divergent POU domain factor highly expressed in layer IV of the neocortex. J. Biol. Chem. 268:23390-23398.
2. Biben, C., B. J. Kirschbaum, L. Garner, and M. Buckingham. 1994. Novel muscle-specific enhancer sequences upstream of the cardiac actin gene. Mol. Cell. Biol. 14:3504-3513.
3. Biben, C., J. Hadchouel, S. Tajbakhsh, and M. Buckingham. 1996. Developmental and tissue-specific regulation of the murine cardiac actin gene in vivo depends on distinct skeletal and cardiac muscle-specific enhancer elements in addition to the proximal promoter. Dev. Biol. 173:200-212.
4. Black, B. L., and E. N. Olson. 1998. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 14:167-196.
5. Buckingham, M., and S. Tajbakhsh. 1999. Myogenic cell specification during somitogenesis, p. 617-633. In S. A. Moody (ed.), Cell lineage and fate determination. Academic Press, New York, N.Y.
6. Catala, F., R. Wanner, P. Barton, A. Cohen, W. Wright, and M. Buckingham. 1995. A skeletal muscle-specific enhancer regulated by factors binding to E and CArG boxes is present in the promoter of the mouse myosin light-chain 1A gene. Mol. Cell. Biol. 15:4585-4596.
7. Chen, S. L., D. H. Dowhan, B. M. Hosking, and G. E. Muscat. 2000. The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation. Genes Dev. 14:1209-1228.
8. Cui, H., and R. F. Bulleit. 1997. Expression of the POU transcription factor Brn-5 inhibits proliferation of NG108-15 cells. Biochem. Biophys. Res. Commun. 236:693-696.
9. Cui, H., and R. F. Bulleit. 1998. Expression of the POU transcription factor Brn5 is an early event in the terminal differentiation of CNS neurons. J. Neurosci. Res. 52:625-632.
10. Czerjesi, P., B. Lilly, C. Hinkley, M. Perry, and E. N. Olson. 1994. Homeodomain protein MHox and MADS protein myocyte enhancer-binding factor-2 converge on a common element in the muscle creatine kinase enhancer. J. Biol. Chem. 269:16740-16745.
11. Dhalluin, C., J. E. Carlson, L. Zeng, H. Cheng, A. K. Aggarwal, and M. M. Zhou. 1999. Structure and ligand of a histone acetyltransferase bromodomain. Nature 399:491-496.
12. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
13. Di Lisi, R., C. Millino, E. Calabria, F. Altruda, S. Schiaffino, and S. Ausoni. 1998. Combinatorial cis-acting elements control tissue-specific activation of the cardiac troponin I gene in vitro and in vivo. J. Biol. Chem. 273:25371-25380.
14. Dominov, J. A., and J. B. Miller. 1996. POU homeodomain genes and myogenesis. Dev. Genet. 19:108-118.
15. Dressel, U., P. J. Bailey, S. C. Wang, M. Downes, R. M. Evans, and G. E. Muscat. 2001. A dynamic role for HDAC7 in MEF2-mediated muscle differentiation. J. Biol. Chem. 276:17007-17013.
16. Eckner, R., T. P. Yao, E. Oldread, and D. M. Livingston. 1996. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev. 10:2478-2490.
17. Ferrari, S., R. Battini, and S. Molinari. 1994. Specific binding to vitamin D response elements of chicken intestinal DNA-binding activity is not related to the vitamin D receptor. Mol. Endocrinol. 8:173-181.
18. Garner, I., A. J. Minty, S. Alonso, P. J. Barton, and M. E. Buckingham. 1986. A 5′ duplication of the α-cardiac actin gene in BALB/c mice is associated with abnormal levels of α-cardiac and α-skeletal actin mRNAs in adult cardiac tissue. EMBO J. 5:2559-2567.
19. Garner, I., D. Sassoon, J. Vandekerckhove, S. Alonso, and M. E. Buckingham. 1989. A developmental study of the abnormal expression of α-cardiac and α-skeletal actins in the striated muscle of a mutant mouse. Dev. Biol. 134:236-245.
20. Gerber, A. N., T. R. Klesert, D. A. Bergstrom, and S. J. Tapscott. 1997. Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: a mechanism for lineage determination in myogenesis. Genes Dev. 11:436-450.
21. Gossett, L. A., D. J. Kelvin, E. A. Sternberg, and E. N. Olson. 1989. A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes. Mol. Cell. Biol. 9:5022-5033.
22. Han, T. H., and R. Prywes. 1995. Regulatory role of MEF2D in serum induction of the c-jun promoter. Mol. Cell. Biol. 15:2907-2915.
23. Hinkley, C., and M. Perry. 1991. A variant octamer motif in a Xenopus H2B histone gene promoter is not required for transcription in frog oocytes. Mol. Cell. Biol. 11:641-654.
24. Jaynes, J. B., J. E. Johnson, J. N. Buskin, C. I. Gartside, and S. D. Hauschka. 1988. The muscle creatine kinase gene is regulated by multiple upstream elements, including a muscle-specific enhancer. Mol. Cell. Biol. 8:62-70.
25. Johansen, T., U. Moens, T. Holm, A. Fjose, and S. Krauss. 1993. Zebrafish pou(c): a divergent POU family gene ubiquitously expressed during embryogenesis. Nucleic Acids Res. 21:475-483.
26. Kelly, R. G., P. S. Zammit, A. Schneider, S. Alonso, C. Biben, and M. E. Buckingham. 1997. Embryonic and foetal myogenic programmes act through separate enhancers at the MLC1F/3F locus. Dev. Biol. 187:183-199.
27. Kouzarides, T. 2000. Acetylation: a regulatory modification to rival phosphorylation? EMBO J. 19:1176-1179.
28. Lakish, M. M., T. T. Diagana, D. L. North, and R. G. Whalen. 1998. MEF-2 and Oct-1 bind to two homologous promoter sequence elements and participate in the expression of a skeletal muscle-specific gene. J. Biol. Chem. 273:15217-15226.
29. Lemercier, C., A. Verdel, B. Galloo, S. Curtet, M. P. Brocard, and S. Khochbin. 2000. mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity. J. Biol. Chem. 275:15594-15599.
30. Liu, Q., J. Schwartz, C. Bucana, and E. N. Olson. 1997. Control of cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276:1404-1407.
31. Lu, J., T. A. McKinsey, C. L. Zhang., and E. N. Olson. 2000. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol. Cell 6:233-244.
32. Mal, A., M. Sturniolo, R. L. Schiltz, M. K. Ghosh, and M. L. Harter. 2001. A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program. EMBO J. 20:1739-1753.
33. Martin, J. F., J. M. Miano, C. M. Hustad, N. G. Copeland, N. A. Jenkins, and E. N. Olson. 1994. A MEF2 gene that generates a muscle-specific isoform via alternative mRNA splicing. Mol. Cell. Biol. 14:1647-1656.
34. Maxam, A. M., and W. Gilbert. 1980. Sequencing end-labelled DNA with base-specific chemical cleavages. Methods Enzymol. 65:499-560.
35. McKinsey, T. A., C. L. Zhang, and E. N. Olson. 2001. Control of muscle development by dueling HATs and HDACs. Curr. Opin. Genet. Dev. 11: 497-504.
36. Messier, H., H. Brickner, J. Gaikwad, and A. Fotedar. 1993. A novel POU domain protein which binds to the T-cell receptor β-enhancer. Mol. Cell. Biol. 13:5450-5460.
37. Minty, A. J., S. Alonso, M. Caravatti, and M. E. Buckingham. 1982. A fetal skeletal muscle actin mRNA in the mouse and its identity with cardiac actin mRNA. Cell 30:185-192.
38. Miska, E. A., C. Karlsson, E. Langley, S. J. Nielsen, J. Pines, and T. Kouzarides. 1999. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J. 18:5099-5107.
39. Missero, C., E. Calautti, R. Eckner, J. Chin, L. H. Tsai, D. M. Livingston, and G. P. Dotto. 1995. Involvement of the cell-cycle inhibitor CipI/WAFI and the EIA-associated p300 protein in terminal differentiation. Proc. Natl. Acad. Sci. USA 92:5451-5455.
40. Molkentin, J. D., B. L. Black, J. F. Martin, and E. N. Olson. 1995. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83:1125-1136.
41. Murphy, S., J. B. Yoon, T. Gerster, and R. G. Roeder. 1992. Oct-1 and Oct-2 potentiate functional interactions of a transcription factor with the proximal sequence element of small nuclear RNA genes. Mol. Cell. Biol. 12:3247-3261.
42. Okamoto, K., M. Wakamiya, S. Noji, E. Koyama, S. Taniguchi, R. Takemura, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, M. Muramatsu, and H. Hamada. 1993. A novel class of murine POU gene predominantly expressed in central nervous system. J. Biol. Chem. 268:7449-7457.
43. Polesskaya, A., A. Duquet, L. Naguibneva, C. Weise, A. Vervisch, E. Bengal, F. Hucho, P. Robin, and A. Harel-Bellan. 2000. CREB-binding protein/ p300 activates MyoD by acetylation. J. Biol. Chem. 275:34359-34364.
44. Polesskaya, A., L. Naguibneva, L. Fritsch, A. Duquet, A. Ait-Si-Ali, P. Robin, A. Vervisch, L. L. Pritchard, P. Cole, and A. Harel-Bellan. 2001. CBP/p300 and muscle differentiation: no HAT, no muscle. EMBO J. 20:6816-6825.
45. Pontoglio, M., D. M. Faust, A. Doyen, M. Yaniv, and M. C. Weiss. 1997. Hepatocyte nuclear factor 1α gene inactivation impairs chromatin remodeling and demethylation of the phenylalanine hydroxylase gene. Mol. Cell. Biol. 17:4948-4956.
46. Puri, P. L., M. L. Avantaggiati, C. Balsano, N. Sang, A. Graessmann, A. Giordano, and M. Levrero. 1997. p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J. 16:369-383.
47. Puri, P. L., V. Sartorelli, X. J. Yang, Y. Hamamori, W. Ogryzko, B. H. Howard, L. Kedes, J. Y. Wang, A. Graessmann, Y. Nakatani, and M. Levrero. 1997. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol. Cell 1:35-45.
48. Raguz, S., C. Hobbs, E. Yague, P. A. Ioannou, F. S. Walsh, and M. Antoniou. 1998. Muscle-specific locus control region activity associated with the human desmin gene. Dev. Biol. 201:26-42.
49. a. Relaix, F., S. Molinari, M. Lemonnier, B. Schäfer, and M. Buckingham. The in vivo form of the murine class VI POU protein Emb is larger than that encoded by previously described transcripts. Gene, in press.
50. Rhee, J. M., C. A. Gruber, T. B. Brodie, M. Trieu, and E. E. Turner. 1998. Highly co-operative homodimerization is a conserved property of neural POU proteins. J. Biol. Chem. 273:34196-34205.
51. Sartorelli, V., J. Huang, Y. Hamamori, and L. Kedes. 1997. Molecular mechanisms of myogenic coactivation by p300: indirect interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol. Cell. Biol. 17:1010-1026.
52. Sartorelli, V., P. L. Puri, Y. Hamamori, V. Ogrysko, G. Chung, Y. Nakatani, J. Y. Wang, and L. Kedes. 1999. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. Mol. Cell 4:725-734.
53. Schreiber, E., K. Harshman, L. Kemler, U. Malipiero, W. Schaffner, and A. Fontana. 1990. Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteins. Nucleic Acids Res. 18:5495-5503.
54. Seed, B., and J. Y. Sheen. 1988. A simple phase-extraction assay for chloramphenicol acyltransferase activity. Gene 67:271-277.
55. Sive, H. L., and R. G. Roeder. 1986. Interaction of a common factor with conserved promoter and enhancer sequences in histone H2B, immunoglobulin, and U2 small nuclear RNA (snRNA) genes. Proc. Natl. Acad. Sci. USA 83:6382-6386.
56. Slepak, T. I., K. A. Webster, J. Zang, H. Prentice, A. O'Dowd, M. N. Hicks, and N. H. Bishopric. 2001. Control of cardiac-specific transcription by p300 through myocyte enhancer factor-2D. J. Biol. Chem. 276:7575-7585.
57. Soutoglou, E., B. Viollet, M. Vaxillaire, M. Yaniv, M. Pontoglio, and I. Talianidis. 2001. Transcription factor-dependent regulation of CBP and P/CAF histone acetyltransferase activity. EMBO J. 20:1984-1992.
58. Strahl, B. D., and C. D. Allis. 2000. The language of covalent histone modifications. Nature 403:41-45.
59. Sturm, R. A., and W. Herr. 1998. The POU domain is a bipartite DNA binding structure. Nature 336:601-604.
60. Verrijzer, C. P., M. J. Alkema, W. W. van Weperen, H. C. Van Leeuwen, M. J. Strating, and P. C. van der Vliet. 1992. The DNA binding specificity of the bipartite POU domain and its subdomains. EMBO J. 11:4993-5003.
61. Wang, A. H., N. R. Bertos, M. Vezmar, N. Pelletier, M. Crosato, H. H. Heng, J. Th'ng, J. Han, and X. J. Yang. 1999. HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol. Cell. Biol. 19:7816-7827.
62. West, A. G., M. Gaszner, and G. Felsenfeld. 2002. Insulators: many functions, many mechanisms. Genes Dev. 16:271-288.
63. Wey, E., G. E. Lyons, and B. W. Schäfer. 1994. A human POU domain gene, mPOU, is expressed in developing brain and specific adult tissues. Eur. J. Biochem. 220:753-762.
64. Wey, E., and B. W. Schäfer. 1996. Identification of novel DNA binding sites recognized by the transcription factor mPOU (POU 6F1). Biochem. Biophys. Res. Commun. 220:274-279.
65. Wu, R., M. Jurek, S. Sundarababu, and D. E. Weinstein. 2001. The POU gene Brn5 is induced by neuregulin and is restricted to myelinating Schwann cells. Mol. Cell Neurosci. 17:683-695.
66. Xu, W., D. G. Edmondson, Y. A. Evrard, M. Wakamiya, R. R. Behringer, and S. Y. Roth. 2000. Loss of Gcn512 leads to increased apoptosis and mesodermal defects during mouse development. Nat. Genet. 26:229-232.
67. Yaffé, D., and O. Saxel. 1977. Serial passaging and differentiation of myogenic cells isolated from dystrophic muscle. Nature 270:725-777.
68. Yao, T. P., S. P. Oh, M. Fuchs, N. D. Zhou, L. E. Ch'ng, D. Newsome, R. T. Bronson, E. Li, D. M. Livingstone, and R. Eckner. 1998. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93:361-372.
69. Yuan, W., G. Condorelli, M. Caruso, A. Felsani, and A. Giordano. 1996. Human p300 protein is a coactivator for the transcription factor MyoD. J. Biol. Chem. 271:9009-9013.